Regulations.gov document
05 Reference 3 - Use of NAT on Pooled and Individual Samples from Donors of Whole Blood…
Supporting & Related Material · FDA-2018-D-3197 · posted Sep 25, 2018
Key facts
| Document ID | FDA-2018-D-3197-0006 |
|---|---|
| Title | 05 Reference 3 - Use of NAT on Pooled and Individual Samples from Donors of Whole Blood and Blood Components to Reduce the Risk of Transmission of HIV1 and HCV |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2018-D-3197 |
| Posted | Sep 25, 2018 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: